What is Translucent?
Translucent operates as an AI-powered financial intelligence platform specifically engineered for the complexities of modern healthcare operations. By integrating directly with hospital and medical group data systems, the platform enables administrators to uncover hidden performance insights and facilitate faster, data-driven decision-making. In an industry often characterized by fragmented information and legacy systems, Translucent serves as a critical bridge, offering a unified view of financial and operational health. Its market position is defined by its ability to transform raw clinical and administrative data into a strategic asset, thereby empowering healthcare leaders to improve patient outcomes while simultaneously enhancing fiscal efficiency.
How much funding has Translucent raised?
Translucent has raised a total of $34M across 2 funding rounds:
Seed
$7M
Series A
$27M
Seed (2025): $7M with participation from New Enterprise Associates, Redesign Health, FPV Ventures, and Virtue VC
Series A (2026): $27M led by New Enterprise Associates, GV, FPV Ventures, and Virtue VC
Key Investors in Translucent
New Enterprise Associates
Established in 1977, NEA is a prominent venture capital firm with a long-standing history of supporting entrepreneurs in building transformative businesses across multiple technology and healthcare sectors.
GV
Formerly Google Ventures, this firm provides global financial backing to growth-stage businesses, focusing on enterprise solutions, life sciences, and frontier technology innovations.
FPV Ventures
FPV Ventures is an investment firm that collaborates with mission-driven founders, leveraging a history of successful high-profile acquisitions to provide strategic guidance and capital for scaling innovation.
What's next for Translucent?
With the successful closure of this latest financing round, Translucent is poised to expand its footprint within the enterprise healthcare market. The strategic roadmap likely involves scaling its engineering team to enhance the platform's predictive modeling capabilities and broadening its reach to larger hospital networks. By maintaining a focus on high-impact, data-driven solutions, the company is well-positioned to navigate the evolving regulatory and economic landscape of the healthcare sector. Future growth will likely be characterized by deeper integration with existing electronic health record systems and the development of advanced benchmarking tools that allow medical groups to compare performance metrics against industry standards, further cementing its role as an essential partner for healthcare operators.
See full Translucent company page
